Soligenix SNGX
NASDAQ SNGX
$0.40 +0.02 (+5.50%)
At close: Aug 21, 2026 · 4:00 PM EDT

Soligenix (SNGX) Income towards Parent Company (2010 - 2026)

Soligenix's (SNGX) quarterly Income towards Parent Company came in at -$2.9 million in Q1 2026, up 10.87% YoY from -$2.6 million in Q1 2025, and up 16.97% on a QoQ basis from -$3.5 million in Q4 2025.

Soligenix (SNGX) Income towards Parent Company (2010 - 2026) Analysis & Trends

Soligenix (SNGX) has 17 years of Income towards Parent Company data on file, last reported at -$2.9 million in Q1 2026.

  • Quarterly Income towards Parent Company rose 10.87% year-over-year to -$2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.7 million (down 17.07% YoY) and the FY2025 annual result came in at -$11.1 million, down 34.04% from the prior year.
  • Income towards Parent Company improved to -$2.9 million in Q1 2026, from -$3.5 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of -$1.0 million in Q1 2023 to a low of -$4.3 million in Q1 2022.
  • A 5-year average of -$2.5 million and a median of -$2.4 million in 2022 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2023 — Income towards Parent Company soared 75.95% — and 2024, when it tumbled 86.63%.
  • Tracing SNGX's Income towards Parent Company over 5 years: stood at -$3.8 million in 2022, then jumped by 51.52% to -$1.8 million in 2023, then sank by 86.63% to -$3.4 million in 2024, then declined by 2.3% to -$3.5 million in 2025, then gained by 16.97% to -$2.9 million in 2026.
  • The last three Income towards Parent Company figures came in at -$2.9 million (Q1 2026), -$3.5 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Soligenix 6.45 Mn 6.45 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.10 Mn
Mar 31, 2026 -2.88 Mn
Dec 31, 2025 -3.47 Mn
Sep 30, 2025 -2.58 Mn
Jun 30, 2025 -2.76 Mn
Mar 31, 2025 -3.24 Mn
Dec 31, 2024 -3.40 Mn
Sep 30, 2024 -1.72 Mn
Jun 30, 2024 -1.64 Mn
Mar 31, 2024 -1.92 Mn
Dec 31, 2023 -1.82 Mn
Sep 30, 2023 -1.66 Mn
Jun 30, 2023 -1.61 Mn
Mar 31, 2023 -1.05 Mn
Dec 31, 2022 -3.75 Mn
Sep 30, 2022 -2.15 Mn
Jun 30, 2022 -2.39 Mn
Mar 31, 2022 -4.35 Mn
Dec 31, 2021 -4.70 Mn
Sep 30, 2021 -2.72 Mn